SRPT Projected Dividend Yield
Sarepta Therapeutics Inc ( NASDAQ : SRPT )Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. Co. is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy (Duchenne) and is developing potential therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. 21 YEAR PERFORMANCE RESULTS |
SRPT Dividend History Detail SRPT Dividend News SRPT Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |